Ten-Year Survival of Children with Congenital Anomalies: A European Cohort Study

Svetlana Glinianaia, Judith Rankin, Anna Pierini, Alessio Coi, Michele Santoro, Joachim Tan, Abigail Reid, Garne Ester, Maria Loane, Joanne Given, Clara Cavero-Carbonell, Hermien E.K. de Walle, Miriam Gatt, Mika Gissler, Anna Heino, Babak Khoshnood, Kari Klungsøyr, Nathalie Lelong, Amanda Neville, Daniel ThayerDavid Tucker, Stine Urhøj, Diana Wellesley, Oscar Zurriaga, Joan K Morris

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)
28 Downloads (Pure)


OBJECTIVES: To investigate the survival up to age 10 for children born alive with a major congenital anomaly (CA).
METHODS: This population-based linked cohort study (EUROlinkCAT) linked data on live births from 2005 to 2014 from 13 European CA registries with mortality data. Pooled Kaplan-Meier survival estimates up to age 10 were calculated for these children (77 054 children with isolated structural anomalies and 4011 children with Down syndrome).
RESULTS: The highest mortality of children with isolated structural CAs was within infancy, with survival of 97.3% (95% confidence interval [CI]: 96.6%-98.1%) and 96.9% (95% CI: 96.0%-97.7%) at age 1 and 10, respectively. The 10-year survival exceeded 90% for the majority of specific CAs (27 of 32), with considerable variations between CAs of different severity. Survival of children with a specific isolated anomaly was higher than in all children with the same anomaly when those with associated anomalies were included. For children with Down syndrome, the 10-year survival was significantly higher for those without associated cardiac or digestive system anomalies (97.6%; 95% CI: 96.5%-98.7%) compared with children with Down syndrome associated with a cardiac anomaly (92.3%; 95% CI: 89.4%-95.3%), digestive system anomaly (92.8%; 95% CI: 87.7%-98.2%), or both (88.6%; 95% CI: 83.2%-94.3%).
CONCLUSIONS: Ten-year survival of children born with congenital anomalies in Western Europe from 2005 to 2014 was relatively high. Reliable information on long-term survival of children born with specific CAs is of major importance for parents of these children and for the health care professionals involved in their care.

Original languageEnglish
Article numbere2021053793
Pages (from-to)1-13
Number of pages13
Issue number3
Early online date11 Feb 2022
Publication statusPublished (in print/issue) - 1 Mar 2022

Bibliographical note

FUNDING: Supported by funding from the European Union’s Horizon 2020 Programme for Research and Innovation under grant agreement #733001 (January
2017–December 2021) (https://ec.europa.eu/programmes/horizon2020/en). The funder had no role in the design and conduct of the study; collection,
management, analysis, and interpretation of the data; preparation, or review; and decision to submit the manuscript for publication. The views presented
here are those of the authors only, and the European Commission is not responsible for any use that may be made of the information presented here.


  • Epidemiology
  • Birth Defects
  • Fetus/Newborn Infant
  • Mortality
  • data linkage
  • Pediatrics, Perinatology and Child Health


Dive into the research topics of 'Ten-Year Survival of Children with Congenital Anomalies: A European Cohort Study'. Together they form a unique fingerprint.

Cite this